Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 2/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.43 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11316021 | 0.98 | HRH1 (0.46) | HRH1GRM5HDAC2HDAC8HDAC6 | |
| SCHEMBL9706507 | 0.88 | FFAR1 (0.49) | HRH1HDAC2HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL6571641 | 0.83 | HRH1 (0.50) | HRH1GRM5HDAC2HDAC8HDAC6 | |
| SCHEMBL1286084 | 0.82 | HRH1 (0.53) | HRH1GRM5HDAC2HDAC8HDAC6 | |
| SCHEMBL1624984 | 0.82 | HDAC3 (0.67) | HDAC2HDAC8HDAC6SMN1; SMN2HDAC3 | |
| SCHEMBL17447470 | 0.80 | ALDH1A1 (0.48) | HRH1GRM5HDAC2HDAC8HDAC6 | |
| SCHEMBL7416396 | 0.80 | HRH1 (0.47) | HRH1GRM5HDAC2HDAC8HDAC6 | |
| Hydrochloric Acid SCHEMBL6644828 | 0.80 | HDAC3 (0.64) | HDAC2HDAC8HDAC6SMN1; SMN2HDAC3 | |
| SCHEMBL61491 | 0.79 | HDAC1 (0.69) | HDAC2HDAC8HDAC6SMN1; SMN2HDAC3 | |
| SCHEMBL5724822 | 0.78 | TBXAS1 (0.66) | HRH1TBXAS1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104447509-A | Tirofiban hydrochloride preparation process | HARVEST HUNAN PHARMACEUTICAL TECHNOLOGY CO LTD | 2015-03-25 | — | — | CN | claimed |
| CN-100537536-C | Process for preparation of tirofiban hydrochloride | LUNAN PHARM GROUP CORP (CN) | 2009-09-09 | — | — | CN | claimed |
| CN-1330636-C | Synthesis process of Tilofiban hydrochloride intermediate | LUNAN PHARM GROUP CORP (CN) | 2007-08-08 | — | — | CN | claimed |
| CN-1844099-A | Process for preparation of tirofiban hydrochloride | LUNAN PHARM GROUP CORP (CN) | 2006-10-11 | — | — | CN | claimed |
| CN-1740158-A | Synthesis process of Tilofiban hydrochloride intermediate | LUNAN PHARM GROUP CORP (CN) | 2006-03-01 | — | — | CN | claimed |
| WO-2018126140-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2018-07-05 | — | — | WO | disclosed |
| CN-104447509-A | Tirofiban hydrochloride preparation process | HARVEST HUNAN PHARMACEUTICAL TECHNOLOGY CO LTD | 2015-03-25 | — | — | CN | disclosed |
| CN-102285912-A | Method for preparing N-n-butylsulfonyl-O-(4-(4-pyridyl)-butyl)-L-tyrosine alkyl ester | — | 2011-12-21 | — | — | CN | disclosed |
| CN-100537536-C | Process for preparation of tirofiban hydrochloride | LUNAN PHARM GROUP CORP (CN) | 2009-09-09 | — | — | CN | disclosed |
| CN-1330636-C | Synthesis process of Tilofiban hydrochloride intermediate | LUNAN PHARM GROUP CORP (CN) | 2007-08-08 | — | — | CN | disclosed |
| CN-1844099-A | Process for preparation of tirofiban hydrochloride | LUNAN PHARM GROUP CORP (CN) | 2006-10-11 | — | — | CN | disclosed |
| CN-1740158-A | Synthesis process of Tilofiban hydrochloride intermediate | LUNAN PHARM GROUP CORP (CN) | 2006-03-01 | — | — | CN | disclosed |
| CN-1050832-C | Process for preparing fibrinogen receptor antagonists | MERCK & CO INC (US) | 2000-03-29 | — | — | CN | disclosed |
| EP-0198325-B1 | SUBSTITUTED ANILINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1992-07-15 | — | — | EP | disclosed |
| US-4891429-A | CHEMICAL INTERMEDIATES | HOFFMANN-LA ROCHE INC. (US) | 1990-01-02 | — | — | US | disclosed |
| US-4696930-A | CARDIOVASCULAR DISORDERS, ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1987-09-29 | — | — | US | disclosed |
| EP-0198325-A2 | Substituted aniline derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1986-10-22 | — | — | EP | disclosed |